Division News

Alliance for Cancer Gene Therapy Foundation (ACGT) has announced that Brent Hanks, MD, PhD, assistant professor of medicine (Medical Oncology), is one of three recipients of its 2016 ACGT Young Investigator Grants. 

Neil Spector, MD, Sandra Coates Associate Professor of Medicine (Medical Oncology) and associate professor of pharmacology and cancer biology, recently discussed his book "Gone in a Heartbeat: A Physician's Search for True Healing," with a Huffington Post blogger.

In the interview, Dr. Spector discusses his experience with Lyme disease and the similarities he sees between Lyme disease and cancer:

The Duke Alumni Association has recognized Kimberly Blackwell, MD, professor of medicine (Medical Oncology), with a Distinguished Alumni Award.

​Arif Kamal, MD, assistant professor of medicine (Medical Oncology), recently earned the designation Fellow of the American Academy of Hospice and Palliative Medicine.

Friday will be a particularly busy day in the Department of Medicine. The Department will host two conferences and two of its centers will mark anniversaries with seminars and celebrations.

Duke researchers made a big splash in the news last spring when 60 Minutes featured the success of early clinical trials using a modified poliovirus in the fight against a deadly form of brain cancer.

Steven Patierno, PhD, professor of medicine (Medical Oncology) and deputy director of the Duke Cancer Institute, studies the biological underpinnings of disparities in prostate cancer among African American and Caucasian men.

[video:https://www.youtube.com/watch?t=15&v=X-cbhrlGcC8]

Although being overweight with a high body-mass index (BMI) has long been associated with a higher risk for colorectal cancer, thinner patients might not fare as well after treatment for advanced cancer, according to a new study from Duke Medicine.

Steven Patierno, PhD, professor of medicine (Medical Oncology) and deputy director of the Duke Cancer Institute, talked with the News & Observer about his research on genetic aspect of the disparity in prostate cancer and controversial screening guidelines.

Three of the nation’s largest philanthropies – the Howard Hughes Medical Institute, the Bill & Melinda Gates Foundation, and the Simons Foundation – have announced a new partnership to provide much needed research support to outstanding early-career scientists in the United States.

Through the new Faculty Scholars Program, the philanthropies will invest a total of $148 million in research support over the program’s first five years.